Literature DB >> 20566767

In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum.

Raimunda Sâmia Nogueira Brilhante1, Maria Auxiliadora Bezerra Fechine, Rossana de Aguiar Cordeiro, Marcos Fábio Gadelha Rocha, Joyce Fonteles Ribeiro, André Jalles Monteiro, Rita Amanda Chaves de Lima, Jacó Ricarte Lima Mesquita, Zoilo Pires de Camargo, José Júlio Costa Sidrim.   

Abstract

This study evaluated the in vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum isolated from HIV-positive patients. The drugs were tested by microdilution testing in accordance with the CLSI guidelines. All of the strains were inhibited by sulfamethoxazole-trimethoprim, with MIC ranges of 0.039 (sulfamethoxazole)/0.0078 (trimethoprim) mg/ml to 0.625/0.125 mg/ml for mycelial forms and 0.0025/0.0005 to 0.02/0.004 mg/ml for yeast-like forms. However, in vivo studies are necessary to evaluate the significance of these results.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20566767      PMCID： PMC2934947          DOI： 10.1128/AAC.00793-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species.

Authors:  Javier Afeltra; Jacques F G M Meis; Roxana G Vitale; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 2.  Histoplasmosis: a clinical and laboratory update.

Authors:  Carol A Kauffman
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.

Authors:  R K Li; M A Ciblak; N Nordoff; L Pasarell; D W Warnock; M R McGinnis
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

4.  In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.

Authors:  Aya Yekutiel; Itamar Shalit; Yona Shadkchan; Nir Osherov
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 5.  [Histoplasmosis].

Authors:  Marcelo Simão Ferreira; Aércio Sebastião Borges
Journal:  Rev Soc Bras Med Trop       Date:  2009 Mar-Apr       Impact factor: 1.581

6.  In-vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species.

Authors:  Ahmed Hanafy; Jun Uno; Hiroki Mitani; Yingqian Kang; Yuzuru Mikami
Journal:  Nihon Ishinkin Gakkai Zasshi       Date:  2007

7.  Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.

Authors:  L Joseph Wheat; Alison G Freifeld; Martin B Kleiman; John W Baddley; David S McKinsey; James E Loyd; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2007-08-27       Impact factor: 9.079

8.  African histoplasmosis in Eastern Nigeria: report of two culturally proven cases treated with septrin and amphotericin B.

Authors:  J U Egere; H C Gugnani; A N Okoro; A V Suseelan
Journal:  J Trop Med Hyg       Date:  1978-11

9.  Orbital histoplasmosis due to Histoplasma capsulatum var. duboisii: successful treatment with Septrin.

Authors:  B G Ajayi; B Osuntokun; O Olurin; O O Kale; T A Junaid
Journal:  J Trop Med Hyg       Date:  1986-08

10.  In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms.

Authors:  Toru Nakai; Jun Uno; Fumiaki Ikeda; Shuichi Tawara; Kazuko Nishimura; Makoto Miyaji
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191
View more
  12 in total

1.  Feline histoplasmosis in Brazil: clinical and laboratory aspects and a comparative approach of published reports.

Authors:  Raimunda Sâmia Nogueira Brilhante; Camila Gomes Virginio Coelho; José Júlio Costa Sidrim; Rita Amanda Chaves de Lima; Joyce Fonteles Ribeiro; Rossana Aguiar de Cordeiro; Débora de Souza Collares Maia Castelo-Branco; José Maurício Fonteles Gomes; Lucilene Simões-Mattos; Marcos Renato Franzosi Mattos; Hugo Enrique Orsini Beserra; George Cândido Nogueira; Adriana de Queiroz Pinheiro; Marcos Fábio Gadelha Rocha
Journal:  Mycopathologia       Date:  2011-10-18       Impact factor: 2.574

2.  Antifungal therapeutics for dimorphic fungal pathogens.

Authors:  Kristie D Goughenour; Chad A Rappleye
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

3.  Multicenter Validation of Commercial Antigenuria Reagents To Diagnose Progressive Disseminated Histoplasmosis in People Living with HIV/AIDS in Two Latin American Countries.

Authors:  Diego H Cáceres; Blanca E Samayoa; Eduardo E Arathoon; Beatriz L Gómez; Narda G Medina; Angela M Tobón; Brenda J Guzmán; Danicela Mercado; Angela Restrepo; Tom Chiller
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

4.  Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.

Authors:  Rossana de Aguiar Cordeiro; Francisca Jakelyne de Farias Marques; Raimunda Sâmia Nogueira Brilhante; Kylvia Rocha de Castro E Silva; Charles Ielpo Mourão; Erica Pacheco Caetano; Maria Auxiliadora Bezerra Fechine; Joyce Fonteles Ribeiro; Débora de Souza Collares Maia Castelo-Branco; Rita Amanda Chaves de Lima; Jacó Ricarte Lima Mesquita; Andre Jalles Monteiro; Francisco Airton Castro Rocha; Marcos Fábio Gadelha Rocha; José Júlio Costa Sidrim
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

5.  Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum.

Authors:  Rossana de Aguiar Cordeiro; Francisca Jakelyne de Farias Marques; Rebecca de Aguiar Cordeiro; Marcos Reinaldo da Silva; Angela Donato Maia Malaquias; Charlline Vládia Silva de Melo; Jair Mafezoli; Maria da Conceição Ferreira de Oliveira; Raimunda Sâmia Nogueira Brilhante; Marcos Fábio Gadelha Rocha; Tereza de Jesus Pinheiro Gomes Bandeira; José Júlio Costa Sidrim
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

6.  Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B.

Authors:  R de Aguiar Cordeiro; C I Mourão; M F G Rocha; F J de Farias Marques; C E C Teixeira; D F de Oliveira Miranda; L V P Neto; R S N Brilhante; T de Jesus Pinheiro Gomes Bandeira; J J C Sidrim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-29       Impact factor: 3.267

7.  Loop-mediated Isothermal Amplification and nested PCR of the Internal Transcribed Spacer (ITS) for Histoplasma capsulatum detection.

Authors:  Matheus da Silva Zatti; Thales Domingos Arantes; José Alex Lourenço Fernandes; Mônica Baumgardt Bay; Eveline Pipolo Milan; Georggia Fatima Silva Naliato; Raquel Cordeiro Theodoro
Journal:  PLoS Negl Trop Dis       Date:  2019-08-26

Review 8.  Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors.

Authors:  Agnieszka Wróbel; Karolina Arciszewska; Dawid Maliszewski; Danuta Drozdowska
Journal:  J Antibiot (Tokyo)       Date:  2019-10-02       Impact factor: 2.649

9.  Comparison of diagnostic methods to detect Histoplasma capsulatum in serum and blood samples from AIDS patients.

Authors:  Katia Cristina Dantas; Roseli Santos de Freitas; Marcos Vinicius da Silva; Paulo Ricardo Criado; Olinda do Carmo Luiz; Adriana Pardini Vicentini
Journal:  PLoS One       Date:  2018-01-17       Impact factor: 3.240

10.  Antifungal activity of liriodenine on agents of systemic mycoses, with emphasis on the genus Paracoccidioides.

Authors:  Adriele Dandara Levorato Vinche; Iván de-la-Cruz-Chacón; Alma Rosa González-Esquinca; Julhiany de Fátima da Silva; Gisela Ferreira; Daniela Carvalho Dos Santos; Hans Garcia Garces; Daniela Vanessa Moris de Oliveira; Camila Marçon; Ricardo de Souza Cavalcante; Rinaldo Poncio Mendes
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.